Study Finds Seasonal Flu Vaccines May Boost Cross-Protective Immunity Against H5N1 Through Neuraminidase Antibodies
Researchers analyzed antibodies in 749 human serum samples collected over ten flu seasons and found that seasonal influenza vaccines can increase neuraminidase-inhibiting antibodies that cross-react with H5N1 viruses. Neuraminidase is a viral protein that has been historically overlooked in favor of hemagglutinin in vaccine design and immunity studies. The findings suggest that existing seasonal vaccines may provide some baseline protection against H5N1 and support reconsidering neuraminidase in pandemic preparedness strategies.
A retrospective analysis of human serum samples spanning pre- and post-2009 pandemic periods found detectable neuraminidase-inhibiting antibodies against three genotypes of clade 2.3.4.4b H5N1 viruses across all ten influenza seasons studied. Seasonal inactivated influenza vaccination was associated with a modest but reproducible increase in these cross-reactive antibodies, particularly from the 2009-2010 season onward when A(H1N1)pdm09 was introduced into seasonal vaccine formulations. In contrast, hemagglutinin-directed immunity against H5 remained generally low or undetectable despite detectable HA-reactive antibodies by ELISA. The study used enzyme-linked lectin assay (ELLA) to measure NA-inhibiting antibodies and luciferase-based microneutralization assays to assess neutralizing antibodies. These findings indicate that neuraminidase-specific immunity warrants greater attention in influenza serosurveillance and vaccine evaluation strategies.
What's missing
The study does not specify the demographic characteristics of the 749 individuals sampled, geographic distribution of samples, or whether results varied by age group or prior influenza exposure history. Additionally, the clinical significance of the modest increases in NA-inhibiting titers and their actual protective efficacy against H5N1 infection in humans remains to be determined.
What different sources said
- bioRxivCenter
Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in Humans
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.